Literature DB >> 6699916

Inhibition of fatty acid oxidation and decrease of oxygen consumption of working rat heart by 4-bromocrotonic acid.

J F Hütter, C Schweickhardt, H M Piper, P G Spieckermann.   

Abstract

Nonesterified fatty acids (NEFA), glucose and lactate are major fuels for myocardial energy production. The ratio of energy produced and oxygen consumed, which can be expressed as ATP/O ratio, is different for each substrate: e.g. 3.17 for glucose and 2.83 for palmitate. Direct measurements, however, have shown that the difference of oxygen consumption is about twice as great as theoretically expected. This difference is of little significance under aerobic conditions, but may be important when oxygen supply is restricted. Numerous attempts have been made to reduce oxygen consumption by activating carbohydrate oxidation or inhibiting fatty acid metabolism. As the rate of fatty acid oxidation has been shown to depend on arterial concentrations of NEFA and albumin, this may be one point of control. Further approaches such as increasing the arterial levels of glucose, insulin and potassium, have been controversially discussed. As 4-bromocrotonic acid has been found to inhibit the fatty acid oxidation in isolated rat heart mitochondria [8], this might be an effective agent to save oxygen by reducing the rate of fatty acid oxidation in intact hearts.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6699916     DOI: 10.1016/s0022-2828(84)80718-x

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  17 in total

Review 1.  Free fatty acid metabolism during myocardial ischemia and reperfusion.

Authors:  S C Hendrickson; J D St Louis; J E Lowe; S Abdel-aleem
Journal:  Mol Cell Biochem       Date:  1997-01       Impact factor: 3.396

Review 2.  Are isolated cardiomyocytes a suitable experimental model in all lines of investigation in basic cardiology?

Authors:  H Kammermeier; H Rose
Journal:  Basic Res Cardiol       Date:  1988 Jul-Aug       Impact factor: 17.165

Review 3.  Energy metabolism in the normal and failing heart: potential for therapeutic interventions.

Authors:  William C Stanley; Margaret P Chandler
Journal:  Heart Fail Rev       Date:  2002-04       Impact factor: 4.214

Review 4.  Enhancing the metabolic substrate: PPAR-alpha agonists in heart failure.

Authors:  Satyam Sarma; Hossein Ardehali; Mihai Gheorghiade
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

Review 5.  Hyperglycemia and perioperative glucose management.

Authors:  Andra E Duncan
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

6.  Effects of fatty acid provision during severe hypoxia on routine and maximal performance of the in situ tilapia heart.

Authors:  Ben Speers-Roesch; Sabine L Lague; Anthony P Farrell; Jeffrey G Richards
Journal:  J Comp Physiol B       Date:  2013-03-29       Impact factor: 2.200

Review 7.  Clinical significance of lactate in acute cardiac patients.

Authors:  Chiara Lazzeri; Serafina Valente; Marco Chiostri; Gian Franco Gensini
Journal:  World J Cardiol       Date:  2015-08-26

8.  Effects of POCA on metabolism and function in the ischemic rat heart.

Authors:  D J Paulson; J J Noonan; K M Ward; H Stanley; A Sherratt; A L Shug
Journal:  Basic Res Cardiol       Date:  1986 Mar-Apr       Impact factor: 17.165

Review 9.  Cardiac efficiency.

Authors:  J D Schipke
Journal:  Basic Res Cardiol       Date:  1994 May-Jun       Impact factor: 17.165

10.  Oxygen restriction as challenge test reveals early high-fat-diet-induced changes in glucose and lipid metabolism.

Authors:  Loes P M Duivenvoorde; Evert M van Schothorst; Davina Derous; Inge van der Stelt; Jinit Masania; Naila Rabbani; Paul J Thornalley; Jaap Keijer
Journal:  Pflugers Arch       Date:  2014-07-01       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.